RAGUSA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.036
EU - Europa 965
AS - Asia 225
AF - Africa 79
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.314
Nazione #
US - Stati Uniti d'America 2.013
IT - Italia 402
SE - Svezia 328
BG - Bulgaria 107
CN - Cina 87
VN - Vietnam 79
DE - Germania 52
CI - Costa d'Avorio 39
SG - Singapore 34
CA - Canada 21
GB - Regno Unito 20
SN - Senegal 20
NG - Nigeria 17
IN - India 10
PL - Polonia 10
RU - Federazione Russa 8
AT - Austria 6
FR - Francia 6
BE - Belgio 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
TR - Turchia 4
UA - Ucraina 4
IR - Iran 3
JP - Giappone 3
NL - Olanda 3
AU - Australia 2
EC - Ecuador 2
ES - Italia 2
EU - Europa 2
FI - Finlandia 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.314
Città #
Fairfield 387
Woodbridge 199
Chandler 175
Seattle 156
Ashburn 148
Cambridge 142
Houston 135
Wilmington 129
Milan 122
Serra 120
Sofia 107
Princeton 68
Ann Arbor 58
Lawrence 44
Abidjan 39
Medford 39
Florence 36
Beijing 30
Dong Ket 27
Boulder 26
Redwood City 23
Dakar 20
Bremen 19
San Diego 19
Des Moines 18
Frankfurt am Main 18
Lagos 17
Ottawa 16
Nanjing 15
Dearborn 12
Pisa 11
Rome 11
Washington 11
Norwalk 10
London 8
Warsaw 8
Guangzhou 6
Chengdu 5
Massa 5
Brussels 4
Changsha 4
Fremont 4
San Francisco 4
Shenyang 4
Tianjin 4
Vienna 4
Agliana 3
Bern 3
Boardman 3
Dallas 3
Jiaxing 3
Phoenix 3
Pomezia 3
Absecon 2
Boston 2
Carrara 2
Cascina 2
Cavriglia 2
Gabbro 2
Gunzenhausen 2
Hanover 2
Hefei 2
Islington 2
Kunming 2
Lancaster 2
Nanchang 2
Prague 2
Siena 2
Thornhill 2
Wuhan 2
Almaty 1
Amsterdam 1
Arcola 1
Ardabil 1
Arezzo 1
Azogues 1
Bengaluru 1
Bogotá 1
Boydton 1
Capannori 1
Casalbordino 1
Chicago 1
Chiesina Uzzanese 1
Chiswick 1
Cluj-Napoca 1
Columbia 1
Como 1
Donostia / San Sebastian 1
Dubai 1
Edinburgh 1
Elektrostal 1
Faenza 1
Fuzhou 1
Garbagnate Milanese 1
Grosseto 1
Guayaquil 1
Haikou 1
Hebei 1
Indianapolis 1
Indore 1
Totale 2.552
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 134
Sunitinib in the treatment of thyroid cancer 121
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 113
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 113
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 105
Novel treatment options for anaplastic thyroid cancer 97
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 96
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 96
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 93
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 92
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 89
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 88
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 86
Molecular testing in the diagnosis of differentiated thyroid carcinomas 84
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 83
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis 82
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 81
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 81
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 78
The protective effect of myo-inositol on human thyrocytes 77
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 77
null 75
Novel therapies for thyroid autoimmune diseases: An update 74
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 74
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy 73
Chemokines in hyperthyroidism 72
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 71
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 69
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 69
New insight in endocrine-related adverse events associated to immune checkpoint blockade 65
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 64
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 64
Immune and inflammatory cells in thyroid cancer microenvironment 63
Novel treatments for anaplastic thyroid carcinoma 63
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 62
Th1 chemokines in autoimmune endocrine disorders 57
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 56
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 54
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 53
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 49
Endocrine disruptors and thyroid autoimmunity 44
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 42
L-T4 Therapy in Enteric Malabsorptive Disorders 41
Precision Medicine in Graves’ Disease and Ophthalmopathy 39
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 33
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 24
null 23
Myoinositol in Autoimmune Thyroiditis 20
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 18
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 15
Molecular features of aggressive thyroid cancer 13
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 13
Chemokines in thyroid autoimmunity 12
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 10
Teprotumumab for the treatment of thyroid eye disease 10
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 8
Thyroid Metastasis from Primary Breast Cancer 7
Totale 3.565
Categoria #
all - tutte 8.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019268 0 0 0 2 2 1 41 2 27 40 83 70
2019/2020979 99 40 83 46 61 86 100 108 191 71 57 37
2020/2021482 37 51 50 11 23 24 18 52 33 60 27 96
2021/2022671 13 14 28 47 105 86 28 29 64 49 53 155
2022/2023760 112 100 65 36 67 92 36 45 127 5 61 14
2023/2024290 77 78 124 11 0 0 0 0 0 0 0 0
Totale 3.565